CL monthly performance report
Explore CL's monthly returns, drawdown, and seasonality trends — updated every month.
CL monthly report
—
Key takeaways
- Colgate-Palmolive (CL) closed September 2026 at $87.02, down 3.12% for the month and +6.80% over the trailing 12 months.
- Year-to-date, CL is +10.12%, underperforming the S&P 500 which has returned +10.58% YTD.
- The stock is trading −0.91% versus its 200-day moving average ($87.82), a cautious technical signal.
- Over the past three years, CL has underperformed the S&P 500 by −51.14%, with a relative strength index reading of 69.3.
- Win rate over the trailing 39 months stands at 56.4% — 22 positive months versus 17 negative months.
Colgate-Palmolive ended September 2026 at $87.02, posting a monthly return of −3.12%. The S&P 500 returned −1.69% over the same window, leaving relative performance at −1.42%.
The current quarter stands at −5.08% (Q3 2026 (QTD)), while medium-term trend remains soft: price is −0.91% versus the 200-day moving average ($87.82).
Year-to-date, CL is +10.12% against SPY +10.58%, a gap of −0.45%. The stock is currently −12.39% below its 52-week high, with maximum 3-year drawdown at −31.07%.
| Period | CL | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | +0.02% | −0.44% | +0.46% |
| 1 Week | −1.15% | −1.10% | −0.05% |
| 1 Month | −3.12% | −1.69% | −1.42% |
| 3 Months | −2.72% | −0.10% | −2.61% |
| 6 Months | −2.89% | +13.21% | −16.10% |
| YTD | +10.12% | +10.58% | −0.45% |
| 12 Months | +6.80% | +14.25% | −7.45% |
| 3 Years | +18.93% | +70.07% | −51.14% |
| Rank | Month | Return |
|---|---|---|
| #1 | Jan 2026 | +14.26% |
| #2 | Feb 2026 | +9.80% |
| #3 | Aug 2024 | +7.37% |
| #4 | Oct 2023 | +5.64% |
| #5 | Jan 2024 | +5.63% |
| Rank | Month | Return |
|---|---|---|
| #1 | Mar 2026 | −14.03% |
| #2 | Oct 2024 | −9.73% |
| #3 | Jul 2025 | −7.76% |
| #4 | Dec 2024 | −5.92% |
| #5 | Sep 2025 | −4.91% |
| Quarter | Return |
|---|---|
| Q2 2025 | −2.99% |
| Q3 2025 | −12.06% |
| Q4 2025 | −1.15% |
| Q1 2026 | +7.86% |
| Q2 2026 | +7.57% |
| Q3 2026 (QTD) | −5.08% |
| Year | Return |
|---|---|
| 2023 | +1.17% |
| 2024 | +14.05% |
| 2025 | −13.08% |
| 2026 | +10.12% |
| Metric | Value |
|---|---|
| 52-Week High | $99.33 (2026-02-27) |
| 52-Week Low | $74.55 (2025-11-03) |
| Current Price | $87.02 |
| 200-Day Moving Average | $87.82 |
| Price vs 200DMA | −0.91% |
| 3-Year Maximum Drawdown | −31.07% (2025-11-03) |
| Current Drawdown from 52W High | −12.39% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 69.3 |
| 3-Year Excess Return vs S&P 500 | −51.14% |
| RS Peak | 119.9 (Sep 2024) |
| RS Trough | 65.9 (Nov 2025) |
| Status | Underperforming Benchmark |
Frequently asked questions
What was CL's return for this report period?
CL returned −3.12% in the latest monthly window ending 2026-09-16.
Has CL outperformed SPY year to date?
YTD CL: +10.12% vs SPY: +10.58%.
What is CL's 12-month return?
+6.80% over the trailing 12 months.
Is CL above or below its 200-day moving average?
Price is −0.91% versus 200DMA ($87.82).
What is the maximum drawdown in the 3-year window?
−31.07% on 2025-11-03.